President and Chief Executive Officer
Friends of Cancer Research
Dr. Allen is president and chief executive officer of Friends of Cancer Research (Friends). During the past 20 years, Friends has been instrumental in the creation and implementation of policies ensuring patients receive the best treatments in the fastest and safest way possible.
As a thought leader on many issues related to the U.S. Food and Drug Administration, regulatory strategy and healthcare policy, Dr. Allen is regularly published in prestigious medical journals and policy publications, and has contributed his expertise to the legislative process. Recent Friends initiatives include the establishment of the new Breakthrough Therapies designation and the development of the Lung Cancer Master Protocol, a unique partnership that will accelerate and optimize clinical trial conduct for new drugs.
Dr. Allen received his Ph.D. in cell and molecular biology from Georgetown University.